These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21425135)

  • 21. A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer.
    Burke JP; Power C; Gorey TF; Flanagan F; Kerin MJ; Kell MR
    Eur J Surg Oncol; 2008 Feb; 34(2):149-53. PubMed ID: 17498912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.
    Crosier M; Scott D; Wilson RG; Griffiths CD; May FE; Westley BR
    Clin Cancer Res; 1999 Oct; 5(10):2682-8. PubMed ID: 10537329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases.
    Brewster DH; Stockton DL
    Breast; 2008 Feb; 17(1):104-6. PubMed ID: 17855094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
    Wärnberg F; Bergh J; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological characteristics in screening versus clinically-detected breast cancer].
    Paziault M; Terrade FX; Fermeaux V; Pascal B; Darreye G; Dussartre C; Gilquin M; Labrousse F; Tubiana-Mathieu N
    Bull Cancer; 2006 Jul; 93(7):731-6. PubMed ID: 16873082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA ploidy in screening-detected non-palpable mammary carcinomas.
    von Rosen A; Frisell J; Azavedo E; Auer G
    Eur J Surg Oncol; 1990 Dec; 16(6):471-4. PubMed ID: 2174806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].
    Molinié F; Billon-Delacour S; Allioux C; Blais S; Bercelli P; Lombrail P
    Rev Epidemiol Sante Publique; 2008 Feb; 56(1):41-9. PubMed ID: 18295424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening.
    Arnesson LG; Smeds S; Fagerberg G
    Eur J Surg; 1994 May; 160(5):271-6. PubMed ID: 8075195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program.
    Otten JD; Broeders MJ; Den Heeten GJ; Holland R; Fracheboud J; De Koning HJ; Verbeek AL
    Cancer; 2010 Feb; 116(3):586-91. PubMed ID: 19998346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammographic screening reduces risk of breast carcinoma recurrence.
    Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 13-year follow-up of patients with breast cancer presenting to a District General Hospital breast unit in southeast England.
    Robinson D; Bell J; Møller H; Salman A
    Breast; 2006 Apr; 15(2):173-80. PubMed ID: 16081289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel approach to T classification in tumor-node-metastasis staging of breast cancer.
    Coburn NG; Clarke-Pearson E; Chung MA; Law C; Fulton J; Cady B
    Am J Surg; 2006 Oct; 192(4):434-8. PubMed ID: 16978944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early diagnosis, not differential treatment, explains better survival in service screening.
    Paci E; Ponti A; Zappa M; Patriarca S; Falini P; Delmastro G; Bianchi S; Sapino A; Vezzosi V; Senore C; Crocetti E; Frigerio A; Zanetti R; Del Turco MR; Segnan N
    Eur J Cancer; 2005 Nov; 41(17):2728-34. PubMed ID: 16239106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will screening for breast cancer reduce mortality? Evidence from the first year of screening in Avon.
    Nicholson S; Webb AJ; Coghlan B; Farndon JR; Armstrong JS; Davies JD
    Ann R Coll Surg Engl; 1993 Jan; 75(1):8-11; discussion 12. PubMed ID: 8422159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A note on the cost-benefit problem in screening for breast cancer.
    Kodlin D
    Methods Inf Med; 1972 Oct; 11(4):242-7. PubMed ID: 5084977
    [No Abstract]   [Full Text] [Related]  

  • 38. Aggressiveness of breast cancers detected by screening.
    Duffy SW
    BMJ; 1992 May; 304(6838):1377-8. PubMed ID: 1611345
    [No Abstract]   [Full Text] [Related]  

  • 39. Using clinical databases in practice.
    Black N
    BMJ; 2003 Jan; 326(7379):2-3. PubMed ID: 12511432
    [No Abstract]   [Full Text] [Related]  

  • 40. Breast carcinomas diagnosed in the 1980s.
    Start RD; Cross SS; Smith JH
    BMJ; 1991 Sep; 303(6802):583. PubMed ID: 1912902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.